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ABSTRACT
Clustered Regularly Interspaced Short Palindromic
Repeats (CRISPR) and CRISPR-associated (Cas)
systems in bacteria and archaea use RNA-guided
nuclease activity to provide adaptive immunity
against invading foreign nucleic acids. Here, we
report the use of type II bacterial CRISPR-Cas
system in Saccharomyces cerevisiae for genome en-
gineering. The CRISPR-Cas components, Cas9 gene
and a designer genome targeting CRISPR guide RNA
(gRNA), show robust and specific RNA-guided endo-
nuclease activity at targeted endogenous genomic
loci in yeast. Using constitutive Cas9 expression
and a transient gRNA cassette, we show that
targeted double-strand breaks can increase homolo-
gous recombination rates of single- and double-
stranded oligonucleotide donors by 5-fold and
130-fold, respectively. In addition, co-transformation
of a gRNA plasmid and a donor DNA in cells con-
stitutively expressing Cas9 resulted in near 100%
donor DNA recombination frequency. Our approach
provides foundations for a simple and powerful
genome engineering tool for site-specific mutagen-
esis and allelic replacement in yeast.
INTRODUCTION
Clustered Regularly Interspaced Short Palindromic
Repeats (CRISPR) and CRISPR-associated (Cas)
immune systems in bacteria are of interest to the biotech-
nology community owing to RNA-guided endonuclease
activity (1,2). The Cas9 gene, from the type II bacterial
CRISPR system of Streptococcus pyogenes, complexes
with a designer genome targeting CRISPR guide RNA
(gRNA) to determine the site speciﬁcity of the DNA
cutting activity (2,3) (Figure 1A). It has been shown that
Cas9 can function as an RNA-guided endonuclease in
heterologous organisms (4–8). In the future, engineered
versions of the Cas9 gene could function as a RNA-
guided DNA binding protein, lacking endonuclease
activity. CRISPR systems offer an advantage to zinc
ﬁnger and transcription activator-like effector DNA-
binding proteins, as the site speciﬁcity in nucleotide
binding CRISPR-Cas proteins is governed by a RNA
molecule instead of the DNA-binding protein, which can
be more challenging to design and synthesize. To express
RNA without modiﬁcations added by the RNA polymer-
ase II transcription system, RNA polymerase III regula-
tory elements have been used for transcription of
functional gRNA in human cells (4,5).
To examine RNA-guided Cas9 nuclease activity, we
chose to design gRNAs to target the endogenous
genomic negative selectable marker CAN1, a plasma
membrane arginine permease, in haploid yeast cells and
monitor mutation frequency at the locus. As this gene has
a negative selection, its inactivation frequency can be
observed experimentally. Nonsense mutations in CAN1
can be selected with media containing canavanine (a
toxic arginine analogue), which is only imported into
cells containing a functional CAN1 gene (9). Directed
double-strand break at this locus increases mutation fre-
quency owing to errors that occur in the repair pathway
(9,10). The double-strand break can be resolved either by
homologous recombination or through error-prone
non-homologous end joining (11–13). To control for a
potential genome-wide mutator phenotype, the mutation
frequency of the non-targeted endogenous LYP1 gene, a
lysine permease, was monitored by selecting for lyp1
mutants using a toxic lysine analogue, thialysine (14).
The LYP1 and CAN1 genes are on separate chromo-
somes, and local mutation frequency in either locus
should be independent, unless a global mutator phenotype
is present.
We further examined the effects of genomic
CRISPR-Cas activity on single- and double-stranded
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shown that induction of double-strand breaks near the
oligonucleotide-targeting site can increase recombination
efﬁciency by as high as 4000-fold (13). We ﬁrst examined
the effect of CRISPR-Cas on homologous recombination
in Cas9 constitutively expressing cells by transforming a
transient gRNA polymerase chain reaction (PCR) cassette
containing a promoter, the gRNA sequence and a termin-
ator, with an oligonucleotide donor DNA. In this experi-
ment, a positive reporter system (in which gene correction
could be assayed) was chosen to avoid ambiguity from the
negative reporter system where the source of mutations
could be from erroneous double-strand break repair or
donor DNA.
Moreover, we examined the ability for CRISPR-Cas to
stimulate recombination and select against wild-type se-
quences by co-transforming a gRNA plasmid with a
donor DNA that mutates the genomically encoded
protospacer-associated motif (PAM) sequence, a DNA
motif required for cutting. A gRNA expression plasmid
was co-transformed with a donor DNA in cells containing
Cas9 constitutively expressed on plasmid. These cells were
then selected for the gRNA and Cas9 plasmids, and the
recombination frequency at the locus of integration was
determined.
To ease the future use of CRISPR-Cas methods in for
yeast genome engineering, we also calculated the fre-
quency of gRNA target sites in yeast by calculating all
12bpr ‘seed’ sequences crucial for gRNA genomic speciﬁ-
city proximal to a PAM sequence (2,6).
MATERIALS AND METHODS
Strains and media
The Saccharomyces cerevisiae strain used in the CAN1
mutagenesis analysis of the CRISPR system and the
gRNA plasmid/donor DNA transformation in Cas9-ex-
pressing cells was BY4733 (MATa his3D200 trp1D63
leu2D0 met15D0 ura3D0), which was a kind gift from
Fred Winston. Parental BY4733 was grown in YPAD
before transformation and then propagated in the appro-
priate synthetic complete (SC) media minus the auxo-
trophic compound complemented by the plasmids.
Strain VL6-48 (MATa, his3D200, trplD1, ura3-52,
ade2-101, lys2, psi
o, cir ) was used for the homologous
A
B
Figure 1. Diagram of Cas9 complex and schematic of genetic constructs. (A) Illustration of Cas9 protein interacting with CRISPR gRNA to direct
endonuclease activity proximal to the PAM sequence. (B) Design of the Cas9 and gRNA constructs. Cas9 gene contained a SV40 nuclear localization
signal and was expressed under the Gal-L inducible promoter in CAN1 experiments and the TEF1 constitutive promoter in ADE2 experiments. The
gRNA was expressed under the snoRNA SNR52 promoter and contained a terminator from the 30 region of the yeast SUP4 gene. CAN1.Y and
CAN1.Z were targeted to different loci in the CAN1 gene, whereas ADE2.Y and ADE2.Z were targeted to different loci in the ADE2 gene.
Nucleic Acids Research,2013, Vol.41, No. 7 4337recombination experiments using the gRNA PCR
product, owing to its native ade2-101 premature stop
codon.VL6-48 was purchased from ATCC (MYA-3666).
Plasmids p415-Gal-L and p426-Gal1 used in this study
were a kind gift from Fred Winston (15).
Plasmid construction
The Cas9 gene was a codon-optimized version originally
constructed for expression in human cells (4). This gene
was C-terminally tagged with a SV40 nuclear localization
signal. The p415 Gal-L and p414 TEF1p plasmids were
each cut with XhoI and XmaI, and the backbone contain-
ing the promoter and terminator was gel puriﬁed. Cas9
was PCR ampliﬁed from a TOPO-TA vector with 20
base pair extended 50 and 30 regions identical to the
promoter and terminator of the destined plasmid
backbone (either p415 Gal-Lp or p414 TEF1p). The
PCR ampliﬁed Cas9 was Gibson assembled into the
vector using the NEB Gibson Assembly kit. For the
gRNA expression plasmids, the p426-Gal1 plasmid was
cut with XhoI and SacI to remove the Gal1 promoter,
and the backbone was gel puriﬁed. The gRNA expression
cassette containing the SNR52 promoter, the gRNA and
SUP4 30 ﬂanking sequence were assembled by two rounds
of PCR using Phusion 2X HF Master Mix. The outer two
primers contained 20 base pair extended 50 and 30 regions
identical to the p426-Gal1 plasmid backbone at the cut
sites. In the ﬁrst round of PCR contained all primers at
10nM. The second round of PCR was a 50-ml reaction
containing a 2ml of 10-fold dilution of the ﬁrst round
product with the outer primers at concentrations of
10nM. For the CAN1 experiments, the gRNA PCR
products were Gibson assembled into the cut p426
plasmid. The KanMX sequence was PCR ampliﬁed with
50bp homology arms to the CAN1 locus from the
pFA6a-KanMX6 plasmid, commonly used for gene
knockout in yeast. See Supplementary Material S1 for
sequences of Cas9 gene and plasmid descriptions.
Transformation of plasmids for CAN1 mutagenesis
Transformation of plasmids (200ng per transformation)
was carried out using astandard lithium acetate transform-
ation method (16). After transformation, cells were plated
on selective media (SC-uracil and leucine, SC-tryptophan
or SC-uracil and tryptophan) and allowed grow for 2 days
until colonies appeared. All oligonucleotides were
purchased from Integrated DNA Technologies
(Coralville, IA, USA). See Supplementary Material S1
for sequences of oligonucleotides. Double-stranded oligo-
nucleotides were generated by annealing equimolar
amounts of single-stranded oligonucleotides by ﬁrst
denaturing the mixture at 100 C for 5 min and then
allowing cool to 25 C with a ramp of 0.1 C per second.
Electroporation of transient gRNA cassette and
oligonucleotides
The gRNA cassette and donor single-stranded or
double-stranded oligonucleotide were transformed into
VL6-48 cells containing p414 TEFp Cas9 via electropor-
ation as follows. Cultures were grown to saturation
overnight in SC-tryptophan. The next morning, a 10 ml
culture was inoculated in liquid SC-tryptophan to and
OD600=0.3. Inoculated cells were grown in roller
drum at 30 C until OD600=1.8 after 5h. Cells were col-
lected via centrifugation at 2250g for 3 min and the media
removed. The cell pellet was washed once by 10ml ice-cold
water and once by 10ml of ice-cold electroporation buffer
(1M Sorbitol/1mM CaCl2). The cells were conditioned by
re-suspending the cell pellet in 2 ml 500mM LiAc/10mM
Dithiothreitol (DTT) and placed in roller drum for 30 min
at 30 C. Conditioned cells were collected by centrifugation
and washed once by 10ml ice-cold electroporation buffer.
The cell pellet was re-suspended to a ﬁnal volume of 1.6ml
in electroporation Buffer. In all, 400ml of cells were used
per electroporation with 1nmol of oligonucleotide and
1mg gRNA cassette (or 1mg of salmon sperm DNA as a
control). Cells were electroporated at 2.5kV, 25mF, 200.
Electroporated cells were transferred from each cuvette
into 7ml of 1:1 mix of 1M sorbitol/YPAD media. The
cells were incubated in a roller drum at 30 C for 12h.
Approximately 10
6–10
7 cells were plated on selective
media, and cells were diluted appropriately on rich
media. The ratio of colony count on selective plates over
rich plates was used as a measure of correction frequency.
Experiments were completed in quadruplicate.
Transformation of gRNA plasmid with donor DNA into
Cas9-expressing cells
In all, 500ng of either empty p426 or p426 containing a
gRNA CAN1.Y expression cassette were transformed into
BY4741 cells constitutively expressing Cas9 under the
TEF1 promoter in a p414 plasmid backbone. The p426
plasmid was co-transformed with either 1nmol of double
stranded CAN1.Y oligonucleotide, 5mg of KanMX
cassette and 50mg of salmon sperm DNA, or just 50mg
of salmon sperm DNA, using a standard lithium acetate
transformation method (16). Cells were plated without
dilution on SC without uracil and tryptophan and 10
 5
dilutions onto Yeast Peptone Adenine Dextrose (YPAD)
and allowed to recover for 2 days before the selective
plates were replica plated to canavanine plates and
YPAD plates with 100mg/ml G418 antibiotic (Geneticin
G418, purchased from Teknova). Transformation fre-
quency was calculated by the ratio of number cells that
recover on SC without uracil and tryptophan divided by
the number on rich non-selective media. No donor DNA
experiments were completed with three replicates, and the
transformations containing donor DNA were completed
with six replicates.
Galactose induction of Cas9
Cells were grown in 5 ml SC dropout without leucine and
uracil media containing 2% glucose to saturation, washed
twice in water and then inoculated to an OD=0.3 in SC
dropout without leucine and uracil media containing 2%
galactose and 1% rafﬁnose. Cells were allowed to grow for
16hours before plating on YPAD, SC-arginine plates con-
taining 60mg/ml L-canavanine (Sigma) and SC-lysine con-
taining 100mg/ml thialysine (S-2-aminoethyl-l-cysteine,
Sigma). In all, 10
7–10
8 cells were plated on canavanine
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appropriately on rich media. The ratio of colony count
on canavanine or thialysine plates divided by the colony
count on rich media plates for each culture was used as a
measure of mutation frequency. Experiments were
completed in quadruplicate. Sequence alignments of
Sanger sequence ﬁles were completed using Lasergene
Seqman Pro Software (17).
Toxicity of CRISPR system
To analyse the toxicity associated with of the Cas9 protein
and gRNA, strains were grown in 5 ml SC dropout media
containing 2% glucose to an OD=2.0, washed twice in
5ml water and then equal amounts of cells plated in on
both YPAD and YPA Gal (2% galactose and 1% rafﬁn-
ose) and allowed to grow at 30 C for 2 days. Experiments
were completed in quadruplicate.
Identiﬁcation of CRISPR-Cas targets in yeast genome
Both strands of the complete the S. cerevisiae S288c
genome (version R64-1-1, GenBank assembly
GCA_000146045.2) were searched for sequences of the
form N(21)GG that did not contain any string of six or
more Ts, yielding 924177 candidate Cas9 target se-
quences. Sequences containing six Ts in a row were
excluded, as they can cause termination of RNA polymer-
ase III transcripts (18,19). The yeast genome was then
searched for other genomic occurrences of the S(12)
‘seed’ sequences (see text) within these targets followed
by NGG using bowtie version one release 0.12.8 using
parameters -l 15 -v 0 -k 2. Speciﬁcally, for each S(12),
the four sequences S(12)AGG, S(12)CGG, S(12)GGG
and S(12)TGG were considered input ‘reads’ to be
mapped against the genome, and any candidate for
whom more than one match was found among these
four reads was rejected (20). All candidates passing this
ﬁlter meet the Cas9 speciﬁcity conditions described in the
text. A second round of seed checks was then performed
using this same method looking for S(12)NAG matches.
Here, targets that returned no matches for any of their
four NAG reads were tagged as NoNAG targets
to denote their greater speciﬁcity. The sequences of
all targets have been provided in a .csv ﬁle in
Supplementary Material S2. Sequence IDs in the header
lines indicate the chromosome and location of the left
endpoint of the sequences in the R64-1-1 version of the
genome, followed by an ‘r’ if the sequence is presented as a
reverse complement. NoNAG tags are provided in the
header line after these IDs where applicable.
RESULTS
The gRNA expression and genomic target identiﬁcation
The RNA polymerase III regulatory elements used in this
study were based on constructs used to express bacterial
tRNA genes in yeast (18,21). Speciﬁcally, the SNR52
snoRNA promoter and the yeast tRNA gene SUP4 30
ﬂanking sequence (as a terminator) were used to express
gRNA (Figure 1B). This combination of promoter and
terminator has been shown to produce transcripts with
strings of U residues less than six ribonucelotides long,
which is an important consideration, as the structural com-
ponent of the gRNA contains a string of four U residues
(4,19,22). The protospacer adjacent motif (PAM)
sequence, a genomically encoded NGG nucleotide
sequence directly 30 of the 20bp genome target, is a
crucial design constraint to the site speciﬁcity. The design
of the gRNA structural component used in this study was
based on the sequence used by Mali et al. (4) for gRNA
expression in human cells (Figure 1A and B). The 20bp of
genome sequence complementary in the gRNA mimics the
processed CRISPR RNA (crRNA) found in the natural
host, S. pyogenes. In this organism, a 39–42 base pair
sequence, containing a 20bp spacer-derived guide
sequence and 19–22 base pair repeat-derived sequence, is
processed by a trans-activating crRNA molecule and
RNAse III enzyme to form functional gRNA. The func-
tional gRNA designs in human cells build on the work of
Jinek et al. (2) who demonstrated in vitro that Cas9
requires both a base paired activating trans-activating
crRNA and the targeting crRNA, or a single chimeric
gRNA with features of each molecule (4,5,23). It has
been reported that mismatches in any of the last 12nt of
the 20nt crRNA against a target dsDNA can ablate Cas9
activity, whereas mismatches in the ﬁrst 8nt have little
effect. Therefore, 23bp sequences of the form
N(8)S(12)NGG for which the 12bp ‘seed’ sequence S(12)
followed by an NGG is found nowhere else in the genome
have the greatest chance of being speciﬁcally targetable by
Cas9. However, partial activity of a NAG PAM sequence
has also been observed for the Cas9 system(6) so that
targets that may be unique genomic S(12)NGG occur-
rences but have one or more S(12)NAG occurrences may
be less speciﬁc. Using these constraints, we tabulated
645392 genomic targets of maximal speciﬁcity (unique
S(12)NGG with no S(12)NAG occurrences) and 108493
genomic targets of lesser speciﬁcity (unique S(12)NGG but
one or more S(12)NAG) (Supplementary Material S2).
CRISPR-Cas directed CAN1 mutagenesis
The CAN1 locus was targeted with gRNA expression con-
structs on high-copy 2m plasmids. The Cas9 gene was
placed under the Gal-L promoter, an attenuated version
of the strongly galactose-inducible Gal1 promoter, in a
centromeric plasmid with  1 copy per cell (Figure 1B)
and only induced with galactose during experiments
(15). We chose to examine Cas9 under an inducible
promoter, at ﬁrst, to limit the potential toxicity of
CRISPR-Cas activity.
Two sites in the CAN1 gene were targeted. gRNA
CAN1.Z was designed to direct endonuclease activity
58bp downstream of the ATG start codon of the CAN1
gene, whereas the gRNA CAN1.Y genomic target site was
located 207bp downstream of the start codon (Figure 2A).
On expression of Cas9 in strains also expressing gRNA,
cell viability decreased to 78 and 89% with CAN1.Y and
CAN1.Z, respectively, whereas strains containing only a
single CRISPR-Cas component had viability near 100%
(Figure 2B). The degree of toxicity also correlates with
Nucleic Acids Research,2013, Vol.41, No. 7 4339higher mutation frequency in the CAN1 locus, as
CAN1.Y was the most toxic gRNA and had the highest
CAN1 mutation frequency. Following galactose induction
of Cas9, the mutation frequency in the CAN1 gene was
0.07 and 0.01% with CAN1.Y and CAN1.Z gRNAs, re-
spectively (Figure 2C). Furthermore, the mutation rate in
the LYP1 gene remained relatively constant across all
strains, suggesting that CRISPR-Cas is site speciﬁc in
yeast and does not induce random mutations
genome-wide (Figure 2C). To further validate that muta-
tions were caused by Cas9 and gRNA activity, the CAN1
gene from eight colonies were Sanger sequenced from the
gRNA CAN1.Y/Cas9 and gRNA CAN1.Z/Cas9
canavanine resistant populations. Indeed, 8/8 colonies
from the gRNA CAN1.Y/Cas9 canavanine resistant
population and 7/8 colonies from the gRNA CAN1.Z/
Cas9 canavanine resistant population were found to
have frameshift CAN1 mutations directly upstream of
their respective PAM sequences (Figure 2D). These muta-
tions are proximal to the putative cleavage site of the Cas9
system, 3bp upstream of the PAM sequence (2,4,5).
CRISPR-Cas stimulated homologous recombination with
donor DNA and transient gRNA PCR cassette
As a test system for donor DNA homologous recombin-
ation, an allele containing a nonsense mutation of the
ADE2 gene, a phosphoribosylaminoimidazole carboxyl-
ase essential for adenine biosynthesis, was targeted for
repair. The ade2-101 allele is common to many yeast
laboratory strains and contains a premature stop codon
AGAAGACGCCGACATAGAGGAGAAGCATATGTACAATG--AGCCGGTCACAACCCTCTTTCACGACGTTGAAGCT
AGAAGACGCCGACATAGAGGAGAAGCATATGTACAATG--AGCCGGTCACAACCCTCTTTCACGACGTTGAAGCT
AGAAGACGCCGACATAGAGGAGAAGCATATGTACAATG--A-CCGGTCACAACCCTCTTTCACGACGTTGAAGCT
AGAAGACGCCGACATAGAGGAGAAGCATATGTACAAT---AGCCGGTCACAACCCTCTTTCACGACGTTGAAGCT
AGAAGACGCCGACATAGAGGAGAAGCATATGTACAATGAAAGCCGGTCACAACCCTCTTTCACGACGTTGAAGCT
AGAAGACGCCGACATAGAGGAGAAGCATATGTACAATGAAAGCCGGTCACAACCCTCTTTCACGACGTTGAAGCT
AGAAGACGCCGACATAGAGGAGAAGCATATGT----------------ACAACCCTCTTTCACGACGTTGAAGCT
AGAAGACGCCGACATAGAGGAGAAGCATATGTACAATG--AGCCGGTCACAACCCTCTTTCACGACGTTGAAGCT
AGAAGACGCCGACATAGAGGAGAAGCATATGTACAAT----------------CCTCTTTCACGACGTTGAAGCT
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Figure 2. CRISPR-Cas mediated genomic mutagenesis. (A) Schematic of the CAN1.Y and CAN1.Z genomic target sequences and respective PAM
sequences in the CAN1 gene. (B) Percentage survival of yeast strains expressing different combinations of Cas9 and gRNA. Only combination of
Cas9 and gRNA caused decrease in cell viability. Error bars represent standard deviation between four experiments. (C) CAN1 and LYP1 mutation
frequency of yeast strains expressing different combinations of Cas9 and gRNA on galactose induction of Cas9. Mutation frequency of CAN1 (the
gRNA-targeted gene) is elevated in strains expressing Cas9 and gRNA, whereas LYP1 (not targeted by gRNA) remained constant. Error bars
represent standard deviation between four experiments. (D) Alignments of CAN1 gene from canavanine-resistant colonies post-galactose induction of
Cas9 in gRNA-expressing strains. The underlined sequence is of the wild-type reference CAN1 gene, whereas the following eight sequences are from
colonies from the population. The PAM sequence is highlighted in purple, whereas the gRNA guiding sequence is highlighted in blue. Nonsense
mutations observed are largely deletions or insertions 50 to the PAM sequence.
4340 Nucleic Acids Research, 2013,Vol.41, No. 7at base 109 owing to a G to T transversion. In this posi-
tively selectable reporter, mutations causing correction of
the mutation would be rare without donor DNA. We
chose to target this mutation using a 90 mer oligonucleo-
tide bearing the correct sequence of the ADE2 gene
centred around the nonsense mutation. In yeast cells con-
stitutively expressing Cas9 under the TEF1 promoter on a
centromeric plasmid, either an ssDNA or dsDNA oligo-
nucleotide containing these sequences were electroporated
with either a transient PCR product of the gRNA cassette
(containing the SNR52 promoter, gRNA sequence and
SUP4 30 ﬂanking region) or salmon sperm DNA (as a
control).
Two sites in the ADE2 gene were chosen to target with
gRNAs based on the proximity of the ade2-101 mutation
(Figure 3A). Cells electroporated with gRNA cassettes
and oligonucleotides showed higher rates of homologous
recombination than compared with cells with only oligo-
nucleotides. The gRNA ADE2.Y had the largest effect on
homologous recombination, improving single and
double-stranded recombination rates 5-fold and
130-fold, respectively (Figure 3B). The activity of
ADE2.Z was not as high as ADE2.Y, potentially for
several reasons. One reason may be that the cut site of
ADE2.Z was within the donor oligonucleotide; therefore,
interactions between the gRNA and oligonucleotide may
have decreased genomic cutting ability. Also, a stretch of
ﬁve U residues within the gRNA genomic targeting region
may have resulted in decreased full-length ADE2.Z tran-
scription efﬁciency RNA polymerase III owing to prema-
ture transcription termination.
CRISPR-Cas stimulated homologous recombination with
donor DNA and gRNA expression plasmid
In cells containing a centromeric plasmid constitutively
expressing Cas9 under the TEF1 promoter, donor DNA
was co-transformed with a high-copy 2m plasmid with and
without gRNA CAN1.Y expression elements. Donor
DNA was designed to recombine within the gRNA
CAN1.Y genomic target using homology arms to the
site. A double-stranded 90 mer oligonucleotide donor
centred around the PAM sequence contained 2bp
changes to mutate the PAM sequence and incorporate a
premature TAG stop codon. A 1.4kb KanMX cassette
(conferring G418 resistance) was as ampliﬁed with 50bp
homology arms to the CAN1.Y target site and was also
designed to disrupt the PAM sequence. On integration,
both DNA donors would result in canavanine resistance.
Selection of cells containing both gRNA.CAN1.Y and
Cas9 plasmids resulted in a reduction of transformation
frequency as compared with cells with a Cas9 plasmid and
an empty vector (Figure 3C). This is likely due to toxicity
of Cas9 DNA cleavage.
Furthermore, co-transformation of donor DNA with
the gRNA.CAN1Y expression plasmid increased the
transformation frequency as compared to a no donor
DNA control (Figure 3C) Colonies containing both
plasmids were then replica plated to canavanine media
as well as rich media with G418 (to select for the
KanMX integration event). Interestingly, the vast
majority (near  100%) of the cells that received donor
DNA selected for the gRNA CAN.1 Y and Cas9
plasmids were canavanine resistant and the same propor-
tion were G418 resistant in the KanMX donor DNA
co-transformation (Figure 3D). A small amount of
transformants (an average of two colonies per replicate)
resulted when gRNA CAN1.Y plasmid was transformed
without donor DNA, all of which were canavanine sensi-
tive (Supplementary Material S1). In the inducible Cas9
system, which lacked mutagenic donor DNA, canavanine
resistant mutants arose with a frequency of 0.07%.Hence,
in the no donor DNA control of this experiment there
were too few transformants to likely observe such a low
frequency. In cells co-transformed with an oligonucleotide
containing a premature stop codon, to ensure that donor
oligonucleotide recombination was the cause of
canavanine resistance, we sequenced eight colonies of the
canavanine resistant population. Indeed, all eight of these
cells contained PAM sequence mutation and premature
stop codon (Supplementary Material S1). These data
suggest that under strong constitutive expression of
Cas9, a genomically targeted gRNA on a plasmid can
both stimulate recombination of donor DNA and select
against wild type sequences with high frequency.
DISCUSSION
CRISPR-Cas has great potential as a foundational tool
for genome engineering in S. cerevisiae owing to the
user-designated site-speciﬁcity of Cas9 endonuclease
activity and the simplicity of gRNA construction.
Yeast genome engineering methods using site-speciﬁc
endonucleases could also beneﬁt greatly from CRISPR
systems. The delitto perfetto method for genomic oligo-
nucleotide recombination in yeast, as described by
Storici et al. (12,13), uses an induced double-strand
break near the site of oligonucleotide recombination to
obtain recombination frequencies of up to 20%. This tech-
nique requires initial targeted insertion of a CORE
cassette containing a selectable marker with an I-SceI
homing endonuclease site and a separate inducibile
I-SceI gene. Using a similar approach, CRISPR-Cas
could greatly simplify this method by removing the
initial step requiring I-SceI endonuclease site integration.
Furthermore, our experiments using a transient PCR
product of the gRNA cassette show that the site speciﬁcity
of the endonuclease could be directed easily using a
non-integrating PCR product. More optimization,
however, is required to attain these high frequencies of
oligonucleotide recombination with a transient gRNA
CRISPR system.
Transformation of donor DNA into cells selected for
the presence of CRIPSR components on plasmids is a
closer comparison with the delitto perfetto system, as
site-speciﬁc DNA cleavage is more likely in all cells than
on a transient PCR cassette. In this experiment, we saw
recombination frequency near 100%, without selection for
the integrated DNA. Removal of the PAM sequence in the
donor DNA allowed recombinant cells to be protected
from CRISPR-Cas activity and likely the associated
Nucleic Acids Research,2013, Vol.41, No. 7 4341toxicity.Althoughwedidnottestthishypothesis,mutations
in the 12bp ‘seed’ sequence, crucial for site speciﬁcity, may
result in similar protection. Given the ease of designing site
speciﬁcityforCRISPR-Castargetswiththehighrecombin-
ationfrequencyachievedforbotha90merdouble-stranded
oligonucleotide and 1.4kb double-stranded DNA cassette,
we believe this method could be extremely valuable for en-
gineering yeast genomes without the need of selectable
markers attached to the integrated DNA.
In addition, the mutagenic capabilities of CRISPR-Cas,
as demonstrated by the CAN1 mutagenesis experiments,
highlight the potential for the use of CRISPR-Cas to
make targeted knockouts. Further improvement in per-
centage mutagenized with an inducible system is needed
before this would be a practical application, as the
described induced Cas9 mutagenesis experiment only
produced knockout rates of at most 0.07%. However,
we have shown that if a mutagenic donor DNA to
TTAATGGCTCCTTTTCCAATCCTCTTGATATCGAAAAACTAGCTgAAAAATGTGATGTGCTAACGATTGAGATTGAGCATGTTGATGTTC
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Figure 3. The gRNA and donor DNA recombination in Cas9 constitutively expressing strains. (A) Diagram of ADE2 gene in the 50–30 direction
displaying the gRNA genomic target regions and their respective PAM sequences. The sequence location of the single- or double-stranded oligo-
nucleotide that will repair the premature stop codon is also displayed. The single-stranded oligonucleotide is from the non-coding strand of the
ADE2 gene, whereas the double-stranded oligonucleotide is composed of annealed non-coding and coding strands. The oligonucleotide was designed
centred around the mutant base pair. The gRNA sequences were designed based on the closest PAM sequences to the premature stop codon. (B)9 0
mer single- and double-stranded oligonucleotides were electroporated into yeast expressing Cas9 under the TEF1 constitutive promoter, with and
without a gRNA cassette. The gRNA cassette is a PCR product consisting of the SNR52 promoter, the genomic target, the guiding RNA scaffold
and the SUP4 30 ﬂanking sequence. Electroporation of oligonucleotide and ADE.Y gRNA cassette increases oligonucleotide incorporation up to
5-fold for single-stranded oligonucleotide and 130-fold for double-stranded oligonucleotide. Approximately 10
6–10
7 cells were plated on selective
media to monitor ADE2 correction frequency. Values are averages from four experiments, and error bars represent standard deviation from the
experiments. (C) Transformation frequency of plasmid with and without gRNA CAN1.Y expression in cells containing Cas9 constitutively expressed
on a second plasmid. Transformation frequency is deﬁned by the ratio of number colonies that recover on deﬁned media to select for both plasmids
divided by the number of colonies on rich non-selective media. The plasmid transformation frequency decreases when gRNA expression is present on
the plasmid, as expected owing to cell death associated with Cas9 DNA cleavage. (D) Percentage of cells containing gRNA and constitutive Cas9
plasmids resistant to Canavanine and G418 via replica plating. When a CAN1.Y double-stranded oligonucleotide or a KanMX resistance cassette
targeted for disruption of the CAN1 and the CAN1.Y PAM sequence were co-transformed with the gRNA expression plasmid, nearly 100% of the
cells selected for Cas9 and gRNA plasmids were resistant to canavanine. Furthermore, in the case of the KanMX resistance cassette donor DNA, the
same percentage of cells resistant to canavanine was also resistant to G418, indicating all KanMX insertions integrated in the targeted locus. Values
for Figure 3C and D represent an average of three experiments for the no donor DNA controls and six experiments for the transformations
containing donor DNA. Error bars represent standard deviation of values.
4342 Nucleic Acids Research, 2013,Vol.41, No. 7knockout the target gene is provided for homologous re-
combination, this frequency can be dramatically boosted.
One exciting ﬁnding of this study was the use of a tran-
sient gRNA cassette to stimulate homologous recombin-
ation. Because no plasmids or selectable markers were
needed to produce functional gRNA in Cas9-expressing
cells, many gRNAs can thus be easily synthesized and
combinatorially transformed. This could allow for
genomic targeting of many loci at once. Moreover,
studies in several organisms have shown that multiple
genomic targets are possible with the Cas9 system (4–6).
Indeed, in the future, we plan to target multiple sites with
gRNAs simultaneously, either on a plasmid or in a tran-
sient PCR product (potentially in an array form), and
examine the possibility of CRISPR-Cas directed multiplex
genome engineering towards engineering whole metabolic
pathways and large gene networks.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Materials 1 and 2.
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